Clinical Research Directory
Browse clinical research sites, groups, and studies.
Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver Disease
Sponsor: HepQuant, LLC
Summary
This is a study to measure liver recovery in patients with recent alcohol-associated liver injury by assessing liver function and physiology using HepQuant DuO. The HepQuant DuO Test is a blood-based test that involves a drink of a natural compound, cholate, and 2 blood samples at 20 and 60 minutes. The study team is collecting clinical and laboratory data to better monitor and treat patients who have been affected by alcohol-associated liver disease. The study has 4 visits at an outpatient clinic at 1, 3, 6, and 12 months. At each of these visits, participants will undergo a HepQuant DuO test and other standard tests. In addition, the study team will ask about a participant's alcohol use, symptoms, and quality of life.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
40
Start Date
2025-06-10
Completion Date
2032-03
Last Updated
2025-07-11
Healthy Volunteers
No
Interventions
HepQuant DuO Test
HepQuant DuO is commercially available in the U.S. as a Laboratory Developed Test (LDT), but it will be used in this study as a nonsignificant risk investigational device to measure change in liver function over time.
Locations (1)
Stanford University Dept. of Medicine -Gastroenterology & Hepatology
Redwood City, California, United States